ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

THTX Theratechnologies Inc

1.28
-0.06 (-4.48%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Theratechnologies Inc THTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.06 -4.48% 1.28 07:39:15
始値 安値 高値 終値 前日終値
1.31 1.27 1.32 1.28 1.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0220:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
2024/4/1605:15GLOBETheratechnologies Announces Mailing of Management Proxy..
2024/4/1120:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
2024/4/1020:30GLOBETheratechnologies Reports Financial Results and Provides..
2024/4/1020:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
2024/4/0905:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
2024/4/0600:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
2024/4/0320:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
2024/3/2820:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
2024/3/2222:36GLOBETheratechnologies Announces Update on its Preclinical..
2024/3/2209:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
2024/3/2120:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
2024/3/0106:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0106:34GLOBETheratechnologies Announces the Resignation of One of Its..
2024/2/2722:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2721:30GLOBETheratechnologies Receives Refusal to File Letter for..
2024/2/2122:01EDGAR2Form 20-F - Annual and transition report of foreign private..
2024/2/2122:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2121:30GLOBETheratechnologies Reports Financial Results for the Fourth..
2024/2/2021:30GLOBETheratechnologies Announces Publication in Frontiers in..
2024/2/1522:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1521:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
2024/2/0704:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0621:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
2024/2/0201:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2503:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2421:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
2024/1/2404:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2321:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
2024/1/0414:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/0306:28EDGAR2Form F-3/A - Registration statement by foreign private..
2024/1/0223:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
2024/1/0221:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
2023/12/2206:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2206:12PRNCATheratechnologies annonce le renouvellement de son..
2023/12/2206:09PRNCATheratechnologies Announces Renewal of Shelf Prospectus and..
2023/12/2203:21EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/12/1404:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1321:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
2023/11/2906:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/11/2421:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
2023/11/0703:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0702:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0403:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0101:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0101:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
2023/10/2710:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2622:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2621:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
2023/10/2605:13GLOBETheratechnologies Announces Proposed Public Offering of..

最近閲覧した銘柄

Delayed Upgrade Clock